Outcomes | Number of participants (studies) | Certainty of the evidence (GRADE) | Relative effect (95% CI) | Anticipated absolute effects | |
---|---|---|---|---|---|
Risk with mannitol | Risk difference with hypertonic saline | ||||
Brain Relaxation* | 745 | ⨁⨁⨁◯ | OR 1.84 | 67 per 100 | 12 more per 100 |
(10 RCTs) | Moderatea | (1.31 to 2.59) | (6 more to 17 more) | ||
Total urine output* | 615 | ⨁⨁⨁◯ | – | – | SMD 0.75 SD lower |
(7 RCTs) | Moderateb | (0.92 lower to 0.22 lower) | |||
Serum osmolality | 164 | ⨁◯◯◯ | – | The mean serum osmolality was 296.6 mOsm/L | MD 1.97 mOsm/L higher |
(3 RCTs) | Very lowb,c | (3.05 lower to 7 higher) | |||
Arterial sodium* | 328 | ⨁⨁◯◯ | – | The mean arterial sodium was 132 mmol/L | MD 12.69 mmol/L higher |
(3 RCTs) | Lowb,c | (10.85 higher to 14.53 higher) | |||
Serum sodium* | 253 | ⨁⨁⨁◯ | – | The mean serum sodium was 138 mmol/L | MD 4.5 mmol/L higher |
(5 RCTs) | Moderatec | (3.65 higher to 5.35 higher) | |||
Fluid input* | 576 | ⨁⨁⨁◯ | – | – | SMD 0.56 SD lower |
(6 RCTs) | Moderateb | (0.98 lower to 0.15 lower) | |||
Max MAP | 139 | ⨁◯◯◯ | – | The mean max MAP was 84.7 mmHg | MD 1.83 mmHg higher |
(3 RCTs) | Very lowb,c | (1.54 lower to 5.2 higher) | |||
Max CVP | 263 | ⨁⨁◯◯ | – | The mean max CVP was 8.6 mmHg | MD 0.56 mmHg higher |
(RCTs) | Lowc,d | (0.68 lower to 1.8 higher) |